{
    "nct_id": "NCT02859896",
    "official_title": "An Open-Label, Randomized, Parallel Group Study to Assess the Safety and Efficacy of Hectorol® (Doxercalciferol Capsules) in Pediatric Patients With Chronic Kidney Disease Stages 3 and 4 With Secondary Hyperparathyroidism Not Yet on Dialysis",
    "inclusion_criteria": "Inclusion criteria :\n\n* Male or female aged 5 to 18 years old.\n* Weight ≥15 kg.\n* Chronic kidney disease (CKD) Stage 3 or 4 not on dialysis, defined as glomerular filtration rate (GFR) between 15 and 59 mL/min/1.73m^2 (established by Schwartz equation) at Week -2 visit.\n* Intact parathyroid hormone (iPTH) value >100 pg/mL for CKD Stage 3 or >160 pg/mL for CKD Stage 4, at Week -2 visit.\n* Signed informed consent/assent form.\n\nExclusion criteria:\n\n* The patient has a serum 25-hydroxyvitamin D level <30 ng/mL at screening.\n* The patient has a corrected calcium ≥10 mg/dL at the Week -2 visit.\n* The patient has a serum phosphorus >4.5 mg/dL for children 13 to 18 years of age; >5.8 mg/dL for children 5 to 12 years of age at the Week -2 visit.\n* The patient is anticipated to require maintenance hemodialysis within 3 months.\n* The patient used cinacalcet or vitamin D sterol therapies such as calcitriol, doxercalciferol, or paricalcitol within 14 days prior to the baseline visit.\n* The patient has a history of, or active, symptomatic heart disease within 12 months prior to the baseline (Week 0) visit.\n* The patient currently has a chronic gastrointestinal disease (ie, malabsorption, severe chronic diarrhea, chronic ulcerative colitis, or ileostomy).\n* The patient currently has primary hyperparathyroidism or has had a total parathyroidectomy.\n* The patient has an active malignancy.\n* The patient is unable to swallow a capsule in size similar to the Hectorol® and Rocaltrol® capsules.\n* The patient has a history of sensitivity or allergy to doxercalciferol, calcitriol or other vitamin D analogs.\n* The patient currently uses aluminum or magnesium-based binders.\n\nThe above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.\nHealthy volunteers allowed\nMust have minimum age of 5 Years\nMust have maximum age of 18 Years",
    "exclusion_criteria": "",
    "miscellaneous_criteria": ""
}